Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-01-24

AUTHORS

Tahamtan Ahmadi, Tapan Maniar, Stephen Schuster, Edward Stadtmauer

ABSTRACT

Opinion statementRemarkable progress in elucidating the biology of chronic lymphocytic leukemia (CLL) has been made over the last two decades. Improved understanding of CLL has lead to new prognostic tools and therapeutic options, and holds promise for eventually finding a cure for this disease. Challenges lie in incorporating the various treatment modalities, including chemotherapy, monoclonal antibodies, immunotherapeutic strategies and novel small molecules, into a comprehensive treatment strategy guided by the biological complexity of CLL. More... »

PAGES

16-32

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11864-008-0079-8

DOI

http://dx.doi.org/10.1007/s11864-008-0079-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045975030

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19169831


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "B-Lymphocyte Subsets", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bendamustine Hydrochloride", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD5 Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drugs, Investigational", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunologic Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Lymphocytic, Chronic, B-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm, Residual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrogen Mustard Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmadi", 
        "givenName": "Tahamtan", 
        "id": "sg:person.01240050411.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maniar", 
        "givenName": "Tapan", 
        "id": "sg:person.01113544410.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113544410.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schuster", 
        "givenName": "Stephen", 
        "id": "sg:person.011060364477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "Edward", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.leu.2404584", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009036417", 
          "https://doi.org/10.1038/sj.leu.2404584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1385/mo:22:3:217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022770332", 
          "https://doi.org/10.1385/mo:22:3:217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032957274", 
          "https://doi.org/10.1038/sj.leu.2403354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027457195", 
          "https://doi.org/10.1038/sj.leu.2404441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704593", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044690419", 
          "https://doi.org/10.1038/sj.bmt.1704593"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-01-24", 
    "datePublishedReg": "2009-01-24", 
    "description": "Opinion statementRemarkable progress in elucidating the biology of chronic lymphocytic leukemia (CLL) has been made over the last two decades. Improved understanding of CLL has lead to new prognostic tools and therapeutic options, and holds promise for eventually finding a cure for this disease. Challenges lie in incorporating the various treatment modalities, including chemotherapy, monoclonal antibodies, immunotherapeutic strategies and novel small molecules, into a comprehensive treatment strategy guided by the biological complexity of CLL.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11864-008-0079-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1022080", 
        "issn": [
          "1527-2729", 
          "1534-6277"
        ], 
        "name": "Current Treatment Options in Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1-2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "chronic lymphocytic leukemia", 
      "comprehensive treatment strategy", 
      "new prognostic tool", 
      "immunotherapeutic strategies", 
      "Emerging Therapies", 
      "therapeutic options", 
      "treatment modalities", 
      "treatment strategies", 
      "lymphocytic leukemia", 
      "novel small molecules", 
      "prognostic tool", 
      "monoclonal antibodies", 
      "chemotherapy", 
      "therapy", 
      "leukemia", 
      "disease", 
      "antibodies", 
      "cure", 
      "modalities", 
      "options", 
      "small molecules", 
      "strategies", 
      "biological complexity", 
      "promise", 
      "biology", 
      "decades", 
      "progress", 
      "challenges", 
      "understanding", 
      "molecules", 
      "tool", 
      "new concept", 
      "concept", 
      "complexity"
    ], 
    "name": "Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies", 
    "pagination": "16-32", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045975030"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11864-008-0079-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19169831"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11864-008-0079-8", 
      "https://app.dimensions.ai/details/publication/pub.1045975030"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T09:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11864-008-0079-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11864-008-0079-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11864-008-0079-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11864-008-0079-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11864-008-0079-8'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      22 PREDICATES      82 URIs      69 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11864-008-0079-8 schema:about N07f32235b09d40d9a0c96ea1c5fecdf2
2 N14f953ed91ac4bcd8dd34055a7319d8e
3 N340e02ff91e14a86b2fb0743455c35e6
4 N4146272e61d74fae9d6ea2c0ddb2b62b
5 N493b12f868d54bcfbf5440583930ef08
6 N73f7f45401e448819b6524b865f9fbe9
7 N742a84e669124ef4b6071818f6e6ec87
8 N78910968ac7b47e8bf441cec25e88111
9 N790020078b71465fb6f696c5d56f4622
10 Na9f36c103b8b4125a62a49f82e3b42d7
11 Nbadf4b24a6cd4df8b959cf2a181f4078
12 Ncf1673decda94a07b96c0a81e056f2ad
13 Ncf4809ce4efe4f7da6e91eada758e212
14 Nd24bacb214f1450fb2ac64eb45c16e14
15 Nd366469a2e6b4c4f93ee38293af2b01b
16 Nf34a2f6c7b5548f68625b3369b179475
17 Nf6cb498eb1c6489990d88db31d977c1e
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N3b94cbaa57df4d47b88a6d15d7f01a43
21 schema:citation sg:pub.10.1038/sj.bmt.1704593
22 sg:pub.10.1038/sj.leu.2403354
23 sg:pub.10.1038/sj.leu.2404441
24 sg:pub.10.1038/sj.leu.2404584
25 sg:pub.10.1385/mo:22:3:217
26 schema:datePublished 2009-01-24
27 schema:datePublishedReg 2009-01-24
28 schema:description Opinion statementRemarkable progress in elucidating the biology of chronic lymphocytic leukemia (CLL) has been made over the last two decades. Improved understanding of CLL has lead to new prognostic tools and therapeutic options, and holds promise for eventually finding a cure for this disease. Challenges lie in incorporating the various treatment modalities, including chemotherapy, monoclonal antibodies, immunotherapeutic strategies and novel small molecules, into a comprehensive treatment strategy guided by the biological complexity of CLL.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf N20c7b0c039cd477fada2280787e5babb
33 Nfe3c37e273504bb7ab2ebdcef8fa0807
34 sg:journal.1022080
35 schema:keywords Emerging Therapies
36 antibodies
37 biological complexity
38 biology
39 challenges
40 chemotherapy
41 chronic lymphocytic leukemia
42 complexity
43 comprehensive treatment strategy
44 concept
45 cure
46 decades
47 disease
48 immunotherapeutic strategies
49 leukemia
50 lymphocytic leukemia
51 modalities
52 molecules
53 monoclonal antibodies
54 new concept
55 new prognostic tool
56 novel small molecules
57 options
58 prognostic tool
59 progress
60 promise
61 small molecules
62 strategies
63 therapeutic options
64 therapy
65 tool
66 treatment modalities
67 treatment strategies
68 understanding
69 schema:name Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies
70 schema:pagination 16-32
71 schema:productId N4983dfac0ea44d08b4ce738bfa06d1f4
72 N50cf2c63a7e74162b6b48cce8d3d6742
73 Nfd62dc67cc134b659c3b7974b25bddcc
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045975030
75 https://doi.org/10.1007/s11864-008-0079-8
76 schema:sdDatePublished 2022-05-10T09:56
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher Ne335d16734b5419c994d5e012f8b6111
79 schema:url https://doi.org/10.1007/s11864-008-0079-8
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N07f32235b09d40d9a0c96ea1c5fecdf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Drugs, Investigational
85 rdf:type schema:DefinedTerm
86 N14f953ed91ac4bcd8dd34055a7319d8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Randomized Controlled Trials as Topic
88 rdf:type schema:DefinedTerm
89 N20c7b0c039cd477fada2280787e5babb schema:issueNumber 1-2
90 rdf:type schema:PublicationIssue
91 N340e02ff91e14a86b2fb0743455c35e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Immunologic Factors
93 rdf:type schema:DefinedTerm
94 N3b94cbaa57df4d47b88a6d15d7f01a43 rdf:first sg:person.01240050411.42
95 rdf:rest N45dd8702636e416fb0fdfc108c946f7d
96 N4146272e61d74fae9d6ea2c0ddb2b62b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name CD5 Antigens
98 rdf:type schema:DefinedTerm
99 N45dd8702636e416fb0fdfc108c946f7d rdf:first sg:person.01113544410.19
100 rdf:rest N8a7af9f707fc477f885d261d16553fc5
101 N493b12f868d54bcfbf5440583930ef08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Leukemia, Lymphocytic, Chronic, B-Cell
103 rdf:type schema:DefinedTerm
104 N4983dfac0ea44d08b4ce738bfa06d1f4 schema:name pubmed_id
105 schema:value 19169831
106 rdf:type schema:PropertyValue
107 N50cf2c63a7e74162b6b48cce8d3d6742 schema:name dimensions_id
108 schema:value pub.1045975030
109 rdf:type schema:PropertyValue
110 N73f7f45401e448819b6524b865f9fbe9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Immunotherapy
112 rdf:type schema:DefinedTerm
113 N742a84e669124ef4b6071818f6e6ec87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Salvage Therapy
115 rdf:type schema:DefinedTerm
116 N78910968ac7b47e8bf441cec25e88111 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Prognosis
118 rdf:type schema:DefinedTerm
119 N790020078b71465fb6f696c5d56f4622 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name B-Lymphocyte Subsets
121 rdf:type schema:DefinedTerm
122 N8a7af9f707fc477f885d261d16553fc5 rdf:first sg:person.011060364477.44
123 rdf:rest Nbae7828f7f4c4f90bcb73243b90ffe93
124 Na9f36c103b8b4125a62a49f82e3b42d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antineoplastic Combined Chemotherapy Protocols
126 rdf:type schema:DefinedTerm
127 Nbadf4b24a6cd4df8b959cf2a181f4078 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 Nbae7828f7f4c4f90bcb73243b90ffe93 rdf:first sg:person.01044042041.97
131 rdf:rest rdf:nil
132 Ncf1673decda94a07b96c0a81e056f2ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Neoplasm, Residual
134 rdf:type schema:DefinedTerm
135 Ncf4809ce4efe4f7da6e91eada758e212 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Antibodies, Monoclonal
137 rdf:type schema:DefinedTerm
138 Nd24bacb214f1450fb2ac64eb45c16e14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Bendamustine Hydrochloride
140 rdf:type schema:DefinedTerm
141 Nd366469a2e6b4c4f93ee38293af2b01b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Disease Progression
143 rdf:type schema:DefinedTerm
144 Ne335d16734b5419c994d5e012f8b6111 schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 Nf34a2f6c7b5548f68625b3369b179475 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Nitrogen Mustard Compounds
148 rdf:type schema:DefinedTerm
149 Nf6cb498eb1c6489990d88db31d977c1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Multicenter Studies as Topic
151 rdf:type schema:DefinedTerm
152 Nfd62dc67cc134b659c3b7974b25bddcc schema:name doi
153 schema:value 10.1007/s11864-008-0079-8
154 rdf:type schema:PropertyValue
155 Nfe3c37e273504bb7ab2ebdcef8fa0807 schema:volumeNumber 10
156 rdf:type schema:PublicationVolume
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
161 schema:name Oncology and Carcinogenesis
162 rdf:type schema:DefinedTerm
163 sg:journal.1022080 schema:issn 1527-2729
164 1534-6277
165 schema:name Current Treatment Options in Oncology
166 schema:publisher Springer Nature
167 rdf:type schema:Periodical
168 sg:person.01044042041.97 schema:affiliation grid-institutes:grid.412701.1
169 schema:familyName Stadtmauer
170 schema:givenName Edward
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
172 rdf:type schema:Person
173 sg:person.011060364477.44 schema:affiliation grid-institutes:grid.412701.1
174 schema:familyName Schuster
175 schema:givenName Stephen
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44
177 rdf:type schema:Person
178 sg:person.01113544410.19 schema:affiliation grid-institutes:grid.412701.1
179 schema:familyName Maniar
180 schema:givenName Tapan
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113544410.19
182 rdf:type schema:Person
183 sg:person.01240050411.42 schema:affiliation grid-institutes:grid.412701.1
184 schema:familyName Ahmadi
185 schema:givenName Tahamtan
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42
187 rdf:type schema:Person
188 sg:pub.10.1038/sj.bmt.1704593 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044690419
189 https://doi.org/10.1038/sj.bmt.1704593
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/sj.leu.2403354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032957274
192 https://doi.org/10.1038/sj.leu.2403354
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/sj.leu.2404441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027457195
195 https://doi.org/10.1038/sj.leu.2404441
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/sj.leu.2404584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009036417
198 https://doi.org/10.1038/sj.leu.2404584
199 rdf:type schema:CreativeWork
200 sg:pub.10.1385/mo:22:3:217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022770332
201 https://doi.org/10.1385/mo:22:3:217
202 rdf:type schema:CreativeWork
203 grid-institutes:grid.412701.1 schema:alternateName Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
204 schema:name Hematologic Malignancies Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...